In vivo mutagenesis by the hepatocarcinogen quinoline in the lacZ transgenic mouse: Evidence for its in vivo genotoxicity

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 412, Issue 2, 1998, Pages 161-166

  Suzuki, Takayoshi ^a   Miyata, Yuko ^b   Saeki, Ken Ichi ^b   Kawazoe, Yutaka ^b   Hayashi, Makoto ^a   Sofuni, Toshio ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

In vivo mutation; LacZ gene; Muta(TM)Mouse; Quinoline; Transgenic mouse

Indexed keywords

QUINOLINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMICAL CARCINOGENESIS; FEMALE; GENOTOXICITY; LIVER CANCER; LIVER CARCINOGENESIS; LIVER MICROSOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; CARCINOGENS; DIMETHYLNITROSAMINE; DNA MUTATIONAL ANALYSIS; FEMALE; HEPATECTOMY; LAC OPERON; LIVER; MICE; MICE, TRANSGENIC; MICRONUCLEUS TESTS; MUTAGENICITY TESTS; MUTAGENS; QUINOLINES; RETICULOCYTES;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS MUSCULUS;

EID: 0032579152     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(97)00185-X     Document Type: Article

References (24)

1. Hirao K., Shinohara Y., Tsuda H., Fukushima S., Takahashi M., Ito N. Carcinogenic activity of quinoline on rat liver. Cancer Res. 36:1976;329-335.
2. Shinohara Y., Ogiso T., Hananouchi M., Nakanishi K., Yoshimura T., Ito N. Effect of various factors on the induction of liver tumours in animals by quinoline. Jpn. J. Cancer Res. 68:1977;785-796.
3. Nagao M., Yahagi T., Seino Y., Sugimura T., Ito N. Mutagenicities of quinoline and its derivatives. Mutation Res. 42:1977;335-342.
4. Tada M., Takahashi K., Kawazoe Y. Metabolites of quinoline, a hepatocarcinogen, in a subcellular microsomal system. Chem. Pharm. Bull. 30:1982;3834-3837.
5. Tada M., Takahashi K., Kawazoe Y. Binding of quinoline to nucleic acid in a subcellular microsomal system. Chem.-Biol. Interact. 29:1980;257-266.
6. Takahashi K., Kamiya M., Sengoku Y., Kohda K., Kawazoe Y. Deprivation of the mutagenic property of quinoline: Inhibition of mutagenic metabolism by fluorine substitution. Chem. Pharm. Bull. 36:1988;4630-4633.
7. Kamiya, M., Y. Sengoku, K. Takahashi, K. Kohda and Y. Kawazoe, Antimutagenic structure modification of quinoline: fluorine-substitution at position-3, in: Y. Kuroda, D.M. Shankel, M.D. Waters (Eds.), Antimutagenesis and Anticarcinogenesis, vol. II, 1990, pp. 441-446.
8. Ashby J., Mohammed R., Lefevre P.A., Bandara L. Quinoline: unscheduled DNA synthesis and mitogenesis data from the rat liver in vivo. Environ. Mol. Mutagen. 14:1989;221-228.
9. Lefevre P., Ashby J. Mitogenic activity of quinoline to the rat, mouse, and guinea pig liver: empirical correlations with hepatic carcinogenicity. Environ. Mol. Mutagen. 20:1992;39-43.
10. Collaborative study group organized by T. Suzuki Organ variation in the mutagenicity of ethylnitrosourea in Muta™Mouse: results of the collaborative study on the transgenic mutation assay by JEMS/MMS, Environ. Mol. Mutagen., 28 (1996) 363-375.
11. Hayashi M., Morita T., Sofuni T., Ishidate M. Jr. The micronucleus assay with mouse peripheral blood reticulocytes using acridine orange-coated slides. Mutation Res. 245:1990;245-249. and references cited therein.
12. Suzuki T., Itoh T., Hayashi M., Nishikawa A. Jr., Ikezaki S., Furukawa F., Takahashi M., Sofuni T. Organ variation in the mutagenicity of dimethylnitrosamine in Big Blue mice. Environ. Mol. Mutagen. 28:1996;348-353.
13. Saeki K., Kadoi M., Kawazoe Y., Futakuchi M., Tiwawech D., Shirai T. Modification of the carcinogenic property of quinoline, a hepatocarcinogen, by fluorine atom substitution: evaluation of carcinogenicity by a medium-term assay. Biol. Pharm. Bull. 20:1997;40-43.
14. Gosson J.A., DeLeeuw W.J., Tan C.H., Zwarthoff E.C., Berends F., Lohman P.H.M., Knook D.L., Vijg J. Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo. Proc. Natl. Acad. Sci. USA. 86:1989;7971-7975.
15. Kohler S.W., Provost G.S., Fieck A., Kretz P.L., Bullock W.O., Sorge J.A., Putman D.L., Short J.M. Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice. Proc. Natl. Acad. Sci. USA. 88:1991;7958-7962.
16. Morrison V., Ashby J. A preliminary evaluation of the performance of the Muta Mouse (lacZ) and Big Blue (lacI) transgenic mouse mutation assay. Mutagenesis. 9:1994;367-375.
17. Suzuki T., Hayashi M., Sofuni T. Initial experiences and future directions for transgenic mouse mutation assays. Mutation Res. 307:1994;489-494.
18. Gorelick N.J. Overview of mutation assays in transgenic mice for routine testing. Environ. Mol. Mutagen. 25:1995;218-230.
19. Mirsalis J.C., Monforte J.A., Winegar R.A. Transgenic animal models for detection of in vivo mutations. Ann. Res. Pharmacol. Toxicol. 35:1995;145-164.
20. Suzuki T., Hayashi M., Myhr B.C., Sofuni T. Diethylnitrosamine is mutagenic in liver but not in bone marrow of lacZ transgenic mice (Muta™Mouse). Mammal. Mutat. Soc. Commun. 3:1995;33-39.
21. Tates A.D., Neuteboom I., Hofker M., den Engelse L. A micronucleus technique for detecting clastogenic effects of mutagens/carcinogens (DEN, DMN) in hepatocytes of rat liver in vivo. Mutation Res. 74:1980;11-20.
22. Cliet I., Fournier E., Melcion C., Cordier A. In vivo micronucleus test using mouse hepatocytes. Mutation Res. 216:1989;321-326.
23. Lavoie E.J., Defauw J., Fealy M., Way B.M., McQueen A.A. Carcinogenesis. 12:1991;217-220.
24. Williams G.M. Detection of genotoxic chemicals in the hepatocyte primary culture/DNA repair test. Gann Monogr. Cancer Res. 27:1981;45-55.